<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-molecules-26-01627">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lieder</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Zaunschirm</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Holik</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Ley</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Hans</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Krammer</surname>
    <given-names>G.E.</given-names>
   </name>
   <name>
    <surname>Somoza</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>The Alkamide trans-Pellitorine Targets PPARÎ³ via TRPV1 and TRPA1 to Reduce Lipid Accumulation in Developing 3T3-L1 Adipocytes</article-title>
  <source>Front. Pharm.</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>316</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2017.00316</pub-id>
 </element-citation>
</ref>
